Welcome to Glenmark | Glenmark

About
US
About
US
- Overview Overview
- Evolution The achievements that highlight our journey
- Strategic Priorities Positioned for future success
- Governance The tenets of our functioning
- Board of Directors The people who pave the way for a new world
- Executive Team The team who translates vision into reality
- Awards Striving for Excellence
Responsibility
Responsibility
- Our CommunitiesEnriching lives for a healthier and happier world
- Our PlanetOperating responsibly towards a greener planet
- Our PeopleDedicated to the vision of a better world
  - Equal Opportunity for all
  - Employee Health and Safety
- ReportsOur corporate responsibility reports
  - FY 2019
  - FY 2018
  - FY 2017
  - FY 2016
  - FY 2015
  - FY 2014
  - FY 2013
  - FY 2012
  - FY 2011
- FoundationsSpearheading our social initiatives
  - Glenmark Foundation
  - Glenmark Aquatic Foundation
Products
Products
- Novel Molecular EntitiesInnovating to address unmet medical needs
- FormulationsHigh quality branded and generic medicines for global markets
- APIPartner of choice of world’s leading generic companies
  - Glenmark Life Sciences
Investors
Investors
- Latest AnnouncementsFor Investors and Shareholders
- Financial ResultsGrowing from strength to strength
- Shareholders CornerBe a part of the new world
- Reports & PresentationPerformance in numbers

Careers
Careers
- Where
- People
- Inspire
- Possibilities
Media
- NewsroomLatest and archived press releases
- LibraryResources and information

Glenmark inducted into the Dow Jones Sustainability Indices
(DJSI)Emerging Markets 2018, One of the most prestigious Global Sustainability Benchmarks

Read More
A new way for a new world

At Glenmark, we believe in enriching lives and making a difference to patients all over the world. We constantly strive to find new ways that pave the way for a healthier tomorrow.
Read More
Charting new ways through innovation

We believe innovation is the bedrock for meeting unmet medical needs. Innovation for us, is about finding new ways of doing things differently
Read More
A new world.
A healthier world.

With offices in over 40 countries, 17 manufacturing facilities in five countries and 5 R&D centres worldwide, we work relentlessly towards improving the quality of life of patients across the globe.
Read More
Discovering advance therapies for a new world

We are creating centers of excellence in dermatology, oncology and respiratory therapy. The effort is to develop advance therapies to enrich the lives of patients worldwide.
Read More
A new way for a new world begins with us

Over 13,500 employees from 60 nationalities with one mission – Enriching lives worldwide.
Read More

Products

Delivering high quality affordable medicines to millions of patients worldwide

Responsibility

Our commitment towards the environment, the community and our people

Novel Molecular Entities

Innovating for a healthier tomorrow

INVESTOR CORNER latest announcements

Newspaper Publication of Annual General Meeting Notice

Glenmark AGM Notice 2019

AGM Intimation to the Exchange

Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)

Glenmark’s consolidated revenue at Rs. 23,228.79 Mn. for Q1 FY 2019 – 20

Know More

Sept 17, 2019 News Announcement
Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma
Know More

CAREERS
Glenmark is a leading, research–based global pharmaceutical company
Know More

X

This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details refer to our Terms of Use Policy.